Employees Retirement System of Texas’s Vertex Pharmaceuticals VRTX Stock Holding History

Employees Retirement System of Texas’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45M	Hold	2,918	–	–	0.01%	219
2026 Q1	$1.3M	Hold	2,918	–	–	0.01%	203
2025 Q4	$1.32M	Buy	+2,918	New	+$1.26M	0.01%	229
2025 Q2	–	Sell	-120,200	Closed	-$58.3M	–	564
2025 Q1	$58.3M	Sell	120,200 -1,400	-1%	-$652K	0.53%	60
2024 Q4	$49M	Buy	121,600 +3,600	+3%	+$1.67M	0.42%	77
2024 Q3	$54.9M	Hold	118,000	–	–	0.47%	70
2024 Q2	$55.3M	Hold	118,000	–	–	0.52%	63
2024 Q1	$49.3M	Hold	118,000	–	–	0.54%	67
2023 Q4	$48M	Hold	118,000	–	–	0.56%	64
2023 Q3	$41M	Buy	118,000 +7,000	+6%	+$2.45M	0.61%	56
2023 Q2	$39.1M	Buy	+111,000	New	+$37.4M	0.53%	65
2022 Q4	–	Sell	-81,000	Closed	-$23.5M	–	381
2022 Q3	$23.5M	Buy	81,000 +15,800	+24%	+$4.55M	0.36%	84
2022 Q2	$18.4M	Buy	65,200 +23,000	+55%	+$6.16M	0.26%	97
2022 Q1	$11M	Hold	42,200	–	–	0.13%	185
2021 Q4	$9.27M	Hold	42,200	–	–	0.1%	221
2021 Q3	$7.66M	Sell	42,200 -2,300	-5%	-$449K	0.09%	260
2021 Q2	$8.97M	Sell	44,500 -10,700	-19%	-$2.24M	0.11%	227
2021 Q1	$11.9M	Buy	+55,200	New	+$12.1M	0.15%	169
2020 Q4	–	Sell	-96,200	Closed	-$26.2M	–	733
2020 Q3	$26.2M	Hold	96,200	–	–	0.38%	47
2020 Q2	$27.9M	Sell	96,200 -6,300	-6%	-$1.71M	0.42%	48
2020 Q1	$24.4M	Buy	102,500 +17,000	+20%	+$3.9M	0.47%	41
2019 Q4	$18.7M	Sell	85,500 -15,000	-15%	-$3.04M	0.29%	81
2019 Q3	$17M	Buy	100,500 +13,500	+16%	+$2.39M	0.27%	90
2019 Q2	$16M	Sell	87,000 -1,000	-1%	-$175K	0.24%	91
2019 Q1	$16.2M	Buy	88,000 +47,000	+115%	+$8.68M	0.24%	86
2018 Q4	$6.79M	Sell	41,000 -25,000	-38%	-$4.33M	0.11%	214
2018 Q3	$12.7M	Sell	66,000 -2,000	-3%	-$356K	0.17%	129
2018 Q2	$11.6M	Sell	68,000 -22,000	-24%	-$3.41M	0.16%	141
2018 Q1	$14.7M	Sell	90,000 -32,000	-26%	-$5.23M	0.2%	108
2017 Q4	$18.3M	Sell	122,000 -1,000	-0.8%	-$148K	0.23%	91
2017 Q3	$18.7M	Hold	123,000	–	–	0.24%	86
2017 Q2	$15.9M	Buy	123,000 +56,000	+84%	+$6.74M	0.21%	95
2017 Q1	$7.33M	Hold	67,000	–	–	0.1%	254
2016 Q4	$4.94M	Sell	67,000 -24,000	-26%	-$1.95M	0.07%	369
2016 Q3	$7.94M	Hold	91,000	–	–	0.11%	227
2016 Q2	$7.83M	Sell	91,000 -1,000	-1%	-$86.4K	0.11%	228
2016 Q1	$7.31M	Hold	92,000	–	–	0.1%	226
2015 Q4	$11.6M	Buy	92,000 +27,000	+42%	+$3.26M	0.16%	141
2015 Q3	$6.77M	Buy	65,000 +18,000	+38%	+$2.31M	0.1%	236
2015 Q2	$5.8M	Buy	47,000 +8,000	+21%	+$1.01M	0.08%	312
2015 Q1	$4.6M	Sell	39,000 -1,000	-3%	-$120K	0.06%	387
2014 Q4	$4.75M	Buy	40,000 +11,000	+38%	+$1.24M	0.06%	369
2014 Q3	$3.26M	Buy	29,000 +23,000	+383%	+$2.19M	0.04%	472
2014 Q2	$568K	Sell	6,000 -5,900	-50%	-$414K	0.01%	925
2014 Q1	$842K	Sell	11,900 -3,000	-20%	-$238K	0.01%	871
2013 Q4	$1.11M	Sell	14,900 -30,600	-67%	-$2.13M	0.01%	839
2013 Q3	$3.45M	Sell	45,500 -79,000	-63%	-$6.29M	0.04%	417
2013 Q2	$9.94M	Buy	+124,500	New	+$9.17M	0.12%	158

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Employees Retirement System of Texas's VRTX Position: Q2 2026 in Review

Employees Retirement System of Texas held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 2,918 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #219.

Employees Retirement System of Texas first reported a position in VRTX in Q2 2013 and has held it in 48 quarters since. The position peaked at $58.3M in Q1 2025. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Employees Retirement System of Texas held 2,918 shares of Vertex Pharmaceuticals worth $1.45M as of Q2 2026.
Employees Retirement System of Texas left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.01% of Employees Retirement System of Texas's portfolio in Q2 2026, its #219 holding.
Employees Retirement System of Texas first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
Employees Retirement System of Texas's Vertex Pharmaceuticals position peaked at $58.3M in Q1 2025.
1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Employees Retirement System of Texas's 13F filing for Q2 2026, filed 14 Aug 2026.